Pharmaceutical distribution, through the phenomenon see essence.docVIP

 PAGE \* MERGEFORMAT 12 Pharmaceutical distribution, through the phenomenon see essence From the ‘event’ In contrast circulation ‘dilemma’ In the field of medicine circulation over an incident had occurred last year: Sinopharm, Kyushu and some pharmaceutical distribution companies in the Xinjiang region of the base due to the drug delivery rate does not reach 50% of the standard, by the Xinjiang Health Department warning, serious warning and repaying etc. Different degree of punishment: Sinopharm subsidiary is to be in Tacheng, Aksu, Altay, g state and Kashi and other places warnings and severe warnings are to be repaying in Hotan, Kyushu subsidiary was to be a serious warning in the Ili, in Pakistan states, Aksu, g state, Hotan and other places are to be repaying. This event will once again push the cusp medicine circulation, and much media attention. Although the new standards based medicine catalog of some significance for the distribution of the guide, but the specific implementation of the standards and specifications provinces and regions still under the specific circumstances may be. Thus, the emergence of regional differences based drug delivery standard. Insiders noted that although the problems in the pharmaceutical distribution business, but the substance itself may not be caused by the distribution companies, and the pharmaceutical distribution industry development-related disorder. such as hospitals demand, factory shipments, delivery time, the degree of matching, etc., will result in delivery enterprise distribution rate of less than local standards. We say, whether it is based drugs or drug delivery agents, wholesale or retail, all belong to the contents of the pharmaceutical distribution field, as a domestic pharmaceutical distribution companies, ‘giants’, whether or Kyushu Sinopharm have appeared on the drug distribution problem, then for a large number of pharmaceutical distribution companies is even more of a ‘unprecedented challenges.